Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

VTE Risk with Minimally Invasive Surgery

Obstet Gynecol; ePub 2016 Jun 6; Barber, Gehrig, et al

There are decreased odds of venous thromboembolism (VTE) with minimally invasive surgery for the treatment of endometrial cancer compared with open surgery, a recent study found. A secondary analysis cohort that included 9,948 patients who underwent hysterectomy for the treatment of endometrial cancer from 2008 to 2013 were included. Researchers found:

• 61.9% underwent minimally invasive surgery and 38.1% underwent open surgery.

• Patients undergoing minimally invasive surgery had a lower VTE incidence (0.7%, n=47) than patients undergoing open surgery (2.2%, n=80).

• Minimally invasive surgery remained associated with decreased odds of VTE (aOR, 0.36) compared with open surgery after adjusting for age, BMI, race, operative time, Charlson comorbidity score, and surgical complexity.

Citation: Barber EL, Gehrig PA, Clarke-Pearson DL. Venous thromboembolism in minimally invasive compared with open hysterectomy for endometrial cancer. [Published online ahead of print June 6, 2016]. Obstet Gynecol. doi:10.1097/AOG.0000000000001492.